母亲和新生儿产前接触咔哇的后果：系统评价。
Outcomes of mothers and newborns to prenatal exposure to kratom: a systematic review.
机构信息
Clemson University School of Nursing, Greenville, SC, USA.
University of South Carolina, School of Medicine Greenvillle, Greenville, SC, USA.
出版信息
J Perinatol. 2021 Jun;41(6):1236-1243. doi: 10.1038/s41372-021-00952-8. Epub 2021 Feb 15.
Kratom is a legal, widely available substance that contains opioid agonist alkaloids. Due to the marketing of kratom as an opioid alternative for treatment of pain, anxiety, depression, or to reduce opioid withdrawal symptoms, the use of kratom has increased among persons in the USA including pregnant women. This systematic review of the peer-reviewed literature regarding kratom in relation to maternal and infant outcomes resulted in analysis of six case reports of prenatal kratom exposure. Maternal and infant withdrawal from kratom exposure was described in each case, resulting in pharmacologic treatment for both mothers and infants.
译文：咔特是一种合法的、广泛可得的物质，其中含有阿片类激动剂生物碱。由于咔特被宣传为阿片类药物的替代品，可用于治疗疼痛、焦虑、抑郁或减轻阿片类药物戒断症状，因此，包括孕妇在内的美国人群中咔特的使用有所增加。
这篇关于咔特与母婴结局关系的同行评议文献的系统综述，分析了 6 例产前咔特暴露的病例报告。
在每个病例中都描述了母亲和婴儿对咔特暴露的戒断，结果对母亲和婴儿都进行了药物治疗。
Zotero 插件